WPD Pharmaceuticals Inc.

DB:8SV1 Stock Report

Market Cap: €3.8m

WPD Pharmaceuticals Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Mariusz Olejniczak

Chief executive officer

CA$111.5k

Total compensation

CEO salary percentage100.0%
CEO tenure2.8yrs
CEO ownershipn/a
Management average tenure2.1yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mariusz Olejniczak's remuneration changed compared to WPD Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2021n/an/a

-CA$5m

Jun 30 2021n/an/a

-CA$5m

Mar 31 2021n/an/a

-CA$6m

Dec 31 2020CA$113kCA$113k

-CA$8m

Sep 30 2020n/an/a

-CA$16m

Jun 30 2020n/an/a

-CA$16m

Mar 31 2020n/an/a

-CA$14m

Dec 31 2019CA$46kCA$42k

-CA$12m

Compensation vs Market: Mariusz's total compensation ($USD81.45K) is below average for companies of similar size in the German market ($USD418.12K).

Compensation vs Earnings: Mariusz's compensation has been consistent with company performance over the past year.

CEO

Mariusz Olejniczak

2.8yrs

Tenure

CA$111,462

Compensation

Mr. Mariusz Olejniczak serves as Chief Executive Officer at WPD Pharmaceuticals Inc since December 20, 2019. He is the Chief Executive Officer and Member of Management Board at Westcot Ventures Corp. He is...

Leadership Team

NamePositionTenureCompensationOwnership
Mariusz Olejniczak
Chief Executive Officer2.8yrsCA$111.46kno data
Michael Malana
Chief Financial Officer2.2yrsCA$90.00kno data
Waldemar Priebe
Founder & Chairman of Scientific Advisory Boardno datano data27.59%
€ 1.1m
Katarzyna Suchoszek
Chief Operating Officerless than a yearno datano data
Beata Pajak
Chief Scientific Officerno datano datano data
Marek Sipowicz
Chief Medical Officer2yrsno datano data

2.1yrs

Average Tenure

Experienced Management: 8SV1's management team is considered experienced (2.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Waldemar Priebe
Founder & Chairman of Scientific Advisory Boardno datano data27.59%
€ 1.1m
John Walling
Member of Scientific Advisory Boardno datano datano data
Romuald Harwas
Directorless than a yearno datano data
Liam Corcoran
Director5.3yrsCA$48.00kno data
Teresa Rzepczyk
Independent Director3.5yrsCA$18.00k0.0018%
€ 67.2
Peter Novak
Independent Director2.8yrsno data0.40%
€ 15.3k
Waldemar Debinski
Member of Scientific Advisory Board2.5yrsno datano data

2.8yrs

Average Tenure

Experienced Board: 8SV1's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.